SEDA PHARMA DEVELOPMENT SERVICES LTD.Active
Key figures
Like most small UK companies, SEDA PHARMA DEVELOPMENT SERVICES LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £568,332 (58% of the profit for the year).
Filed accounts2020/21–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | — | — |
| Cash at bank and in hand | 777,550 | 781,392 | 1,786,428 | 518,968 | 3,863,745 |
| Total assets | 1,376,777 | 1,571,690 | 11,875,415 | 13,697,165 | 20,626,894 |
| Total liabilities | 2,231,704 | 2,093,381 | 7,863,066 | 1,700,897 | 8,868,051 |
| Net assets / total equity | 2,037,397 | 2,612,959 | 3,379,917 | 4,369,206 | 11,151,821 |
| Average number of employees | 22 | 28 | 34 | 0 | 0 |
| Dividends paid | — | — | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SEDA PHARMA DEVELOPMENT SERVICES LTD.
Company
SEDA PHARMA DEVELOPMENT SERVICES LTD. is a private limited company registered with Companies House under company number 09442533. It was incorporated on 17 Feb 2015. Its status is active. The registered office is in Stockport (SK8). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts. Net assets were £11,151,821, up 155.2% on the previous year. Cash at bank and in hand was £3,863,745. Total assets were £20,626,894 and total liabilities £8,868,051. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).
Control and charges
One person with significant control is registered. 3 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 3 Mar 2027.